Restatement of Previously Issued Financial Statements - Consolidated Statements of Cash Flows (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Cash flows from operating activities:
Net loss	$ (2,027)	$ (212)	$ (2,448)	$ 5,356
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization			5,161	2,552
Share based compensation			5,196	4,987
Deferred income taxes			(436)	(1,114)
Bad debt expense			53	292
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Accounts receivable			(119)	(324)
Inventories - finished goods			(12,438)	10,053
Prepaid income taxes			65	(927)
Prepaid expenses and other current assets			(2,664)	(771)
Accounts payable			7,929	(3,183)
Sales tax payable			(1,942)	2,291
Accrued expenses and other current liabilities			(1,258)	(1,133)
Net cash (used in) provided by operating activities			(2,808)	18,079
Cash flows from investing activities:
Purchase of minority interest investment in Vetster			(300)	(5,000)
Purchases of property and equipment			(3,260)	(3,329)
Net cash used in investing activities			(39,419)	(8,329)
Cash flows from financing activities:
Dividends paid			(12,419)	(18,402)
Net cash used in financing activities			(12,419)	(18,402)
Net decrease in cash and cash equivalents			(54,646)	(8,652)
Cash and cash equivalents, at beginning of period			104,086	111,080
Cash and cash equivalents, at end of period	$ 49,440	102,428	49,440	102,428
Supplemental disclosure of cash flow information:
Cash paid for income taxes			43	3,870
Dividends payable in accrued expenses and other current liabilities			$ 1,498	1,079
As Previously Reported
Cash flows from operating activities:
Net loss		(19)		5,335
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization				2,552
Share based compensation				4,987
Deferred income taxes				(471)
Bad debt expense				292
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Accounts receivable				(324)
Inventories - finished goods				10,053
Prepaid income taxes				(927)
Prepaid expenses and other current assets				(771)
Accounts payable				(3,183)
Sales tax payable				0
Accrued expenses and other current liabilities				536
Net cash (used in) provided by operating activities				18,079
Cash flows from investing activities:
Purchase of minority interest investment in Vetster				(5,000)
Purchases of property and equipment				(3,329)
Net cash used in investing activities				(8,329)
Cash flows from financing activities:
Dividends paid				(18,402)
Net cash used in financing activities				(18,402)
Net decrease in cash and cash equivalents				(8,652)
Cash and cash equivalents, at beginning of period				111,080
Cash and cash equivalents, at end of period		102,428		102,428
Supplemental disclosure of cash flow information:
Cash paid for income taxes				3,870
Dividends payable in accrued expenses and other current liabilities				1,079
Restatement Adjustments
Cash flows from operating activities:
Net loss		(193)		21
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Depreciation and amortization				0
Share based compensation				0
Deferred income taxes				(643)
Bad debt expense				0
(Increase) decrease in operating assets and increase (decrease) in operating liabilities:
Accounts receivable				0
Inventories - finished goods				0
Prepaid income taxes				0
Prepaid expenses and other current assets				0
Accounts payable				0
Sales tax payable				2,291
Accrued expenses and other current liabilities				(1,669)
Net cash (used in) provided by operating activities				0
Cash flows from investing activities:
Purchase of minority interest investment in Vetster				0
Purchases of property and equipment				0
Net cash used in investing activities				0
Cash flows from financing activities:
Dividends paid				0
Net cash used in financing activities				0
Net decrease in cash and cash equivalents				0
Cash and cash equivalents, at beginning of period				0
Cash and cash equivalents, at end of period		$ 0		0
Supplemental disclosure of cash flow information:
Cash paid for income taxes				0
Dividends payable in accrued expenses and other current liabilities				$ 0